Iterion Therapeutics
Edit

Iterion Therapeutics

https://iteriontherapeutics.com/
Last activity: 20.02.2024
Categories: BioTech
Iterion Therapeutics is developing novel cancer therapeutics targeting nuclear β-catenin, a historically “undruggable” oncology target implicated in cell proliferation.
Mentions
5
Employees: 1-10
Total raised: $17M
Founded date: 2010

Investors 2

Funding Rounds 1

DateSeriesAmountInvestors
17.02.2021Series B$17M-

Mentions in press and media 5

DateTitleDescriptionSource
20.02.2024Iterion Therapeutics Announces First Patient Dosed in Phase ...Iterion Therapeutics, an oncology-focused biopharmaceutical company developing small molecule inhibi...lumiravent...
16.02.2021Iterion Therapeutics Secures $17 Million to Advance Developm...HOUSTON, Feb. 16, 2021 /PRNewswire/ — Iterion Therapeutics, Inc. ("Iterion"), a venture-ba...oaoa.com/l...
16.02.2021Iterion Therapeutics Secures $17 Million to Advance Developm...Series B financing to support ongoing Phase 1/2a clinical trial of Tegavivint in desmoid tumors and ...lumiravent...
16.02.2021Iterion Therapeutics Secures $17 Million to Advance Developm...prnewswire...
16.02.2021Iterion Therapeutics Lands $17M Series B HOUSTON, TX, Iterion Therapeutics has raised $17 million in a Series B financing. >> Click ...vcnewsdail...

Reviews 0

Sign up to leave a review

Sign up Log In